123 related articles for article (PubMed ID: 29083493)
21. Secretion of extracellular hsp90alpha via exosomes increases cancer cell motility: a role for plasminogen activation.
McCready J; Sims JD; Chan D; Jay DG
BMC Cancer; 2010 Jun; 10():294. PubMed ID: 20553606
[TBL] [Abstract][Full Text] [Related]
22. Heat shock protein 90 stimulates rat mesenchymal stem cell migration via PI3K/Akt and ERK1/2 pathways.
Gao F; Hu X; Xie X; Liu X; Wang J
Cell Biochem Biophys; 2015 Jan; 71(1):481-9. PubMed ID: 25287672
[TBL] [Abstract][Full Text] [Related]
23. Secreted heat shock protein 90α (HSP90α) induces nuclear factor-κB-mediated TCF12 protein expression to down-regulate E-cadherin and to enhance colorectal cancer cell migration and invasion.
Chen WS; Chen CC; Chen LL; Lee CC; Huang TS
J Biol Chem; 2013 Mar; 288(13):9001-10. PubMed ID: 23386606
[TBL] [Abstract][Full Text] [Related]
24. A novel epidermal growth factor receptor-signaling platform and its targeted translation in pancreatic cancer.
Gilmour AM; Abdulkhalek S; Cheng TS; Alghamdi F; Jayanth P; O'Shea LK; Geen O; Arvizu LA; Szewczuk MR
Cell Signal; 2013 Dec; 25(12):2587-603. PubMed ID: 23993964
[TBL] [Abstract][Full Text] [Related]
25. Propofol affects the growth and metastasis of pancreatic cancer via ADAM8.
Yu X; Shi J; Wang X; Zhang F
Pharmacol Rep; 2020 Apr; 72(2):418-426. PubMed ID: 32048249
[TBL] [Abstract][Full Text] [Related]
26. Heat-shock protein 90α protects NME1 against degradation and suppresses metastasis of breast cancer.
Zhang Y; Zhao G; Yu L; Wang X; Meng Y; Mao J; Fu Z; Yin Y; Li J; Wang X; Guo C
Br J Cancer; 2023 Nov; 129(10):1679-1691. PubMed ID: 37731021
[TBL] [Abstract][Full Text] [Related]
27. RNAi knockdown of Hop (Hsp70/Hsp90 organising protein) decreases invasion via MMP-2 down regulation.
Walsh N; Larkin A; Swan N; Conlon K; Dowling P; McDermott R; Clynes M
Cancer Lett; 2011 Jul; 306(2):180-9. PubMed ID: 21470770
[TBL] [Abstract][Full Text] [Related]
28. [Anti-metastasis effect of thymoquinone on human pancreatic cancer].
Wu ZH; Chen Z; Shen Y; Huang LL; Jiang P
Yao Xue Xue Bao; 2011 Aug; 46(8):910-4. PubMed ID: 22007514
[TBL] [Abstract][Full Text] [Related]
29. PLCγ1-PKCγ signaling-mediated Hsp90α plasma membrane translocation facilitates tumor metastasis.
Yang J; Song X; Chen Y; Lu XA; Fu Y; Luo Y
Traffic; 2014 Aug; 15(8):861-78. PubMed ID: 24899266
[TBL] [Abstract][Full Text] [Related]
30. Transforming growth factor alpha (TGFalpha)-stimulated secretion of HSP90alpha: using the receptor LRP-1/CD91 to promote human skin cell migration against a TGFbeta-rich environment during wound healing.
Cheng CF; Fan J; Fedesco M; Guan S; Li Y; Bandyopadhyay B; Bright AM; Yerushalmi D; Liang M; Chen M; Han YP; Woodley DT; Li W
Mol Cell Biol; 2008 May; 28(10):3344-58. PubMed ID: 18332123
[TBL] [Abstract][Full Text] [Related]
31. CXCL12-CXCR4 promotes proliferation and invasion of pancreatic cancer cells.
Shen B; Zheng MQ; Lu JW; Jiang Q; Wang TH; Huang XE
Asian Pac J Cancer Prev; 2013; 14(9):5403-8. PubMed ID: 24175834
[TBL] [Abstract][Full Text] [Related]
32. Knockdown of angiopoietin-2 suppresses metastasis in human pancreatic carcinoma by reduced matrix metalloproteinase-2.
Zhang ZX; Zhou J; Zhang Y; Zhu DM; Li DC; Zhao H
Mol Biotechnol; 2013 Mar; 53(3):336-44. PubMed ID: 22457202
[TBL] [Abstract][Full Text] [Related]
33. Hsp90 C-terminal inhibitors exhibit antimigratory activity by disrupting the Hsp90α/Aha1 complex in PC3-MM2 cells.
Ghosh S; Shinogle HE; Garg G; Vielhauer GA; Holzbeierlein JM; Dobrowsky RT; Blagg BS
ACS Chem Biol; 2015 Feb; 10(2):577-90. PubMed ID: 25402753
[TBL] [Abstract][Full Text] [Related]
34. Cysteamine suppresses invasion, metastasis and prolongs survival by inhibiting matrix metalloproteinases in a mouse model of human pancreatic cancer.
Fujisawa T; Rubin B; Suzuki A; Patel PS; Gahl WA; Joshi BH; Puri RK
PLoS One; 2012; 7(4):e34437. PubMed ID: 22532830
[TBL] [Abstract][Full Text] [Related]
35. TM4SF1 Regulates Pancreatic Cancer Migration and Invasion In Vitro and In Vivo.
Cao J; Yang JC; Ramachandran V; Arumugam T; Deng DF; Li ZS; Xu LM; Logsdon CD
Cell Physiol Biochem; 2016; 39(2):740-50. PubMed ID: 27459514
[TBL] [Abstract][Full Text] [Related]
36. In silico design of small peptide-based Hsp90 inhibitor: a novel anticancer agent.
Gupta UK; Mahanta S; Paul S
Med Hypotheses; 2013 Nov; 81(5):853-61. PubMed ID: 24018284
[TBL] [Abstract][Full Text] [Related]
37. Norepinephrine-induced invasion by pancreatic cancer cells is inhibited by propranolol.
Guo K; Ma Q; Wang L; Hu H; Li J; Zhang D; Zhang M
Oncol Rep; 2009 Oct; 22(4):825-30. PubMed ID: 19724861
[TBL] [Abstract][Full Text] [Related]
38. KAI1 is a potential target for anti-metastasis in pancreatic cancer cells.
Xu JH; Guo XZ; Ren LN; Shao LC; Liu MP
World J Gastroenterol; 2008 Feb; 14(7):1126-32. PubMed ID: 18286698
[TBL] [Abstract][Full Text] [Related]
39. Octyl Gallate Induces Pancreatic Ductal Adenocarcinoma Cell Apoptosis and Suppresses Endothelial-Mesenchymal Transition-Promoted M2-Macrophages, HSP90α Secretion, and Tumor Growth.
Chua KV; Fan CS; Chen CC; Chen LL; Hsieh SC; Huang TS
Cells; 2019 Dec; 9(1):. PubMed ID: 31905895
[TBL] [Abstract][Full Text] [Related]
40. Secreted interleukin-1alpha induces a metastatic phenotype in pancreatic cancer by sustaining a constitutive activation of nuclear factor-kappaB.
Melisi D; Niu J; Chang Z; Xia Q; Peng B; Ishiyama S; Evans DB; Chiao PJ
Mol Cancer Res; 2009 May; 7(5):624-33. PubMed ID: 19435817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
